Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain
13 Agosto 2018 - 11:30AM
Sunnyvale, Aug. 13, 2018 (GLOBE NEWSWIRE) -- August 13, 2018 -
Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences
and personalized medicine company, has been approved for in-store
allergy testing promotions by a major United States retailer.
Arrayit sales and marketing experts will conduct allergy test
promotions in-store, and medical professionals at in-store clinics
will collect finger stick blood specimens. Two thousand
retail locations nationwide averaging 3,000 customer visits per
store per day would give Arrayit access to 6 million retail
customers daily, creating the potential for exponential sales
growth. This promotional campaign required rigorous vetting
and high-level corporate approval by the retailer, which reports
revenues exceeding $50 billion annually.
Arrayit recently completed an allergy testing pilot program for
a retail chain, established a nationwide network of 1,700 sales
professionals to sell and distribute the company’s finger stick
microarray tests, met with top officials at the United States Food
and Drug Administration (FDA) regarding FDA approval of a major
product line, reported the sale of clinical instrumentation to the
FDA, and signed allergy testing contracts with a consortium of 178
medical clinics. Doctors can use allergy test results as a
guide to prescribe allergy medicines, immunotherapy, food
elimination and lifestyle changes. The availability of
allergy medicines and immunotherapy products at retail stores,
allows customers to incorporate an allergy test into a convenient
family shopping experience.
Arrayit CEO Rene Schena states, “Winning approval for in-store
promotions by a major US retailer is a significant step in our
mission to make allergy testing more convenient and
accessible. This program fits nicely into our broader
strategy of promoting customer-oriented health and wellness locally
and on a national scale.”
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads
and empowers the research, biotechnology, pharmaceutical, clinical
and healthcare sectors through the discovery, development and
manufacture of proprietary life science and personalized medicine
products and services to advance biomedical research and improve
wellness and human health. Please visit www.arrayit.com for
more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such
as "expect", "believe", and "should". Although we believe our
expectations are reasonable, our operations involve a number of
risks and uncertainties that are beyond our control, and these
statements may turn out not to be true. Risk factors associated
with our business, including some of the facts set forth herein,
are detailed in the Company's public filings.
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
Grafico Azioni Arrayit (CE) (USOTC:ARYC)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Arrayit (CE) (USOTC:ARYC)
Storico
Da Feb 2024 a Feb 2025
